IP Library Granted Patent US 10,776,702
Granted Patent B2
US 10,776,702 · App. 15/688,958 · Granted Sep 15, 2020

Method and system for making customized formulations having a thixotropic hydrocolloid for individuals

Inventors: Edison Thurman Hudson (Chapel Hill, NC); Lloyd Staton Noel (Durham, NC)
Assignee: Panacea Biomatx, Inc.
G06N5/02A61J1/062A61J3/002G06F19/3475
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,776,702
App. No.
15/688,958
Granted
Sep 15, 2020
Kind
B2
Abstract

The one or more embodiments disclosed herein provide a method for automatically assembling multiple compounds into a single edible custom composition, in which each compound is individually customized to proportions formulated from a profile of an individual or group. The single custom mixture can contain a plurality of compounds including foods or flavors, nutritional additives, herbals, biologics, or pharmacologically active substances. Using the method and a related algorithm, the formulation of a custom mixture is suggested.

Claims (32)

1. A method of providing a customized supplement formulation for an individual, the method comprising:

receiving health-related information associated with an individual;

based on the health-related information, determining a suggested formulation for an ingredient for the individual, wherein the suggested formulation includes a plurality of compounds for treatment based on the health-related information;

wherein a filler medium into which the formulation is intermixed comprises a thixotropic semi-solid hydrocolloid;

comparing the filler medium and the suggested formulation to determine whether a combination thereof is suitable for intended purposes; and

dissolving or suspending of compounds of the suggested formulation in a form that is stable until agitated or extruded at which point the semi-solid hydrocolloid becomes fluid and can be dispensed into a dosage.

2. The method of claim 1 , wherein the health-related information includes one of medical history, height, weight, age, and sex of the individual.

3. The method of claim 1 , wherein health-related information further includes one of family history, and allergy profile data of the individual.

4. The method of claim 1 , further comprising, based on receiving taste related preference data, determining a characteristic of the filler medium, wherein taste-related preference data includes taste, texture, and size of dosage.

5. The method of claim 1 , wherein the ingredient is one of a supplement and a pharmaceutical product.

6. The method of claim 1 , wherein the filler medium is selected from polymeric glycosaminoglycans, polysaccharides, or combinations thereof.

7. The method of claim 6 , wherein the polysaccharide is selected from agar, carrageenan, alginate, natural gums, carboxymethyl cellulose, pectin, dextran, dextran derivatives, pullulan, xanthan, xyloglucan, starch, hyaluronic acid, or combinations thereof.

8. The method of claim 1 , wherein the health-related information is provided by a computing device.

9. The method of claim 1 , wherein the health-related information is provided by a healthcare service professional.

10. The method of claim 4 , wherein the taste-related preference data is provided by a computing device.

11. The method of claim 1 , wherein the dosage is configured as a daily dosage.

12. The method of claim 1 , further comprising dispensing the formulation in a uniformly distributed manner.

13. A server comprising:

a memory; and

a processor configured for:

receiving health-related information associated with an individual;

based on the health-related information, determining a suggested formulation for an ingredient for the individual, wherein the suggested formulation includes a plurality of compounds for treatment based on the health-related information;

comparing a filler medium and the suggested formulation to determine whether a combination thereof is suitable for intended purposes; and

wherein a filler medium into which the formulation is intermixed comprises a thixotropic semi-solid hydrocolloid;

directing a mixing apparatus to dissolve or suspend the compounds of the suggested formulation in a form that is stable until agitated or extruded at which point the semi-solid hydrocolloid becomes fluid and can be dispensed into a dosage.

14. The server of claim 13 , wherein the health-related information includes one of medical history, height, weight, age, and sex of the individual.

15. The server of claim 13 , wherein health-related information further includes one of family history, and allergy profile data of the individual.

16. The server of claim 13 , wherein the server is further configured for, based on receiving taste related preference data, determining a characteristic of the filler medium, wherein taste-related preference data includes taste, texture, and size of dosage.

17. The server of claim 13 , wherein the ingredient is one of a supplement and a pharmaceutical product.

18. The server of claim 13 , wherein the filler medium is selected from polymeric glycosaminoglycans, polysaccharides, or combinations thereof.

19. The server of claim 18 , wherein the polysaccharide is selected from agar, carrageenan, alginate, natural gums, carboxymethyl cellulose, pectin, dextran, dextran derivatives, pullulan, xanthan, xyloglucan, starch, hyaluronic acid, or combinations thereof.

20. The server of claim 13 , wherein the health-related information is provided by a computing device.

Assignments (2)
CHANGE OF NAME Recorded Dec 14, 2021
From: PANACEA BIOMATX, INC.
To: ONEFUL HEALTH, INC.
Reel/Frame 058387/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2017
From: HUDSON, EDISON THURMAN; NOEL, LLOYD STATON
To: PANACEA BIOMATX, INC.
Reel/Frame 043628/0521 →
Continuity (4)
Continuation 15620915 · Jun 13, 2017
Division 14207364 · Mar 12, 2014
Provisional Application 61777181 · Mar 12, 2013
Related Publication 20170357898A1 · Dec 14, 2017